Login Get Started
Browse Breadcrumb chevron Shares Breadcrumb chevron Healthcare Breadcrumb chevron Pharmaceuticals Breadcrumb chevron Novartis AG
Novartis AG logo

NOVN - Novartis AG Share News

CHF79.49 0.4  0.5%

Last Trade - 07/05/21

Sector
Healthcare
RiskRating
Conservative
Size
Large Cap
Style
Contrarian
Market Cap £140.98bn
Enterprise Value £165.31bn
Revenue £35.93bn
Position in Universe 4th / 1051
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions NOVN Dividends
All News
All News Reuters News Company Announcements
Pfizer asks Swiss OK for COVID-19 vaccine for children 12 to 15
Fri 3:31pm News
UPDATE 1-Switzerland says U.S. stance on vaccine patent waiver leaves questions
Thu 5:53pm News
Switzerland says U.S. announcement on vaccine patent waiver leaves questions
Thu 5:17pm News
German pharma firm Cheplapharm considers options including IPO
Wed 8:19am News
MEDIA-EU eyes joint purchase of COVID treatments in long virus fight- Bloomberg News
Tue 4:58pm News
Refinitiv Newscasts - Breakingviews TV: Drug boost
Tue 3:16pm News
BioNTech CEO says prospective 2021 vaccine output approaching 3 bln doses
Tue 12:08pm News
BREAKINGVIEWS-Drug giants offer pandemic recovery sleeper trade
Tue 10:11am News
BRIEF-BASF To Invest At Novartis' Kundl/Schaftenau Campus In Austria
Mon 2:05pm News
Novartis biosimilar targets rivals' Eylea eye treatment
Mon 6:42am News
BRIEF-Sandoz Confirms Late-Stage Clinical Development Plans For Proposed Biosimilar Aflibercept
Mon 6:17am News
Sandoz confirms late-stage clinical development plans for proposed biosimilar aflibercept, a key ophthalmology medicine
Mon 6:15am News
Swiss stocks - Factors to watch on May 3
Mon 5:33am News
BRIEF-Novartis Phase III Beovu Data Show Potential For Fluid Resolution In More Diabetic Macular Edema Patients With Fewer Injections Versus Aflibercept
1st May News
Novartis Phase III Beovu® data show potential for fluid resolution in more diabetic macular edema patients with fewer injections versus aflibercept
1st May News
BRIEF-Novartis Says Ilaris Receives Health Canada Approval As Treatment For Adult-Onset Still's Disease
29th Apr News
UPDATE 1-Novartis pushes back UK cholesterol study's end to 2026 on COVID disruption
27th Apr News
Novartis pushes back UK cholesterol study's end to 2026 on COVID interruption
27th Apr News
Refinitiv Newscasts - Novartis catches chill as masks keep flu at bay
27th Apr News
Italy judge sends Bayer, Novartis to trial in drugs fraud probe - sources
27th Apr News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.